Barry Ticho - 15 Mar 2023 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role
Chief Medical Officer
Signature
/s/ Stephen Tulipano, Attorney-in-Fact
Issuer symbol
STOK
Transactions as of
15 Mar 2023
Net transactions value
$0
Form type
4
Filing time
17 Mar 2023, 16:35:02 UTC
Previous filing
07 Feb 2023
Next filing
03 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STOK Employee Stock Option (Right to Buy) Award $0 +78,600 $0.000000 78,600 15 Mar 2023 Common Stock 78,600 $9.15 Direct F1
transaction STOK Restricted Stock Unite (RSU) Award $0 +52,400 $0.000000 52,400 15 Mar 2023 Common Stock 52,400 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/48th of the total shares on April 15, 2023 and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.
F2 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
F3 The RSUs vest as to 1/4th of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the issuer through each vesting date.